Medicated Skin Care in Greece

Date: June 21, 2012
Pages: 35
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M398AF097A4EN
Leaflet:

Download PDF Leaflet

There were no significant developments in medicated skin care in Greece during 2011. The lack of innovation resulted in declining value sales against the background of severe economic recession and shrinking disposable incomes. Financially distressed Greek consumers have become increasingly budget-conscious and many Greek people have made attempts to reduce expenditure wherever possible. For many, the purchase of many medicated skin care products began is now regarded as unnecessary and in many...

Euromonitor International's Medicated Skin Care in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
MEDICATED SKIN CARE IN GREECE

Euromonitor International
June 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Apivita SA in Consumer Health (greece)
Strategic Direction
Key Facts
  Summary 1 ApiVita SA: Key Facts
  Summary 2 ApiVita SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3   Summary ApiVita SA: Competitive Position 2011
Korres Natural Products SA in Consumer Health (greece)
Strategic Direction
Key Facts
  Summary 4 Korres Natural Products SA: Key Facts
  Summary 5 Korres Natural Products SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 6 Korres Natural Products SA: Competitive Position 2011
Uni-pharma SA in Consumer Health (greece)
Strategic Direction
Key Facts
  Summary 7 Uni-Pharma SA: Key Facts
  Summary 8 Uni-Pharma SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 9 Uni-Pharma SA: Competitive Position 2011
Executive Summary
Despite the Recession Consumer Health Grows in 2011
Price Increases, Switches and the 'negative' List Change the Shape of Consumer Health
No Significant Changes Among Leading Consumer Health Players in 2011
Chemists/pharmacies Dominate Value Sales in Consumer Health
Future Performance Relies on Switches and Price Liberation
Key Trends and Developments
Price Increases Trigger Wave of Switches and Subsequent Growth in Consumer Health
Recession Leads To Growing Price Awareness, Yet Quality Remains Decisive Factor in Many Consumer Health Categories
Shrinking Disposable Income Increases Levels of Self- Medication
Focused Positioning and Clear Benefits Rewarded by Consumers
Shrinking Disposable Income Slows Down Momentum of Herbal/traditional Products
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 10 OTC - Switches 2009-2011
Definitions
Sources
  Summary 11 Research Sources
Skip to top


Medicated Skin Care - India US$ 990.00 Mar, 2011 · 34 pages
Medicated Skin Care - Kenya US$ 990.00 Jun, 2010 · 24 pages

Ask Your Question

Medicated Skin Care in Greece
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: